Research graph
References from Pharmacometabolomic study of drug response to antihypertensive medications for hypertension marker identification in Han Chinese individuals in Taiwan. Local targets link to admitted publications; unresolved targets remain external evidence.
Combination therapy in the treatment of hypertension
10.7573/dic.212531 · 2018 · External reference
10.1038/nrdp.2018.14
10.1038/nrdp.2018.14 · External reference
Blood pressure-lowering drugs and secondary prevention of cardiovascular disease: systematic review and meta-analysis
10.1097/hjh.0000000000001720 · 2018 · External reference
Blood pressure, hypertension and the risk of sudden cardiac death: a systematic review and meta-analysis of cohort studies
2019 · External reference
First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension
2018 · External reference
First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension
2015 · External reference
Unresolved reference
External reference
2022 guidelines of the taiwan society of cardiology and the taiwan hypertension society for the management of hypertension
2022 · External reference
Traditional chinese medicine for essential hypertension: a clinical evidence map
10.1155/2020/5471931 · 2020 · External reference
US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008
10.1001/jama.2010.650 · 2010 · External reference
Pharmacogenomics of hypertension: a genome-wide, placebo-controlled cross-over study, using four classes of antihypertensive drugs
10.1161/jaha.114.001521 · 2015 · External reference
Genes for blood pressure: an opportunity to understand hypertension
10.1093/eurheartj/ehs455 · 2013 · External reference
Pharmacogenomics and hypertension: current insights
2019 · External reference
Essential hypertension: a filtered serum based metabolomics study
2017 · External reference
Metabolomics profiling in hypertension and blood pressure regulation: a review
10.1186/s40885-020-00157-9 · 2020 · External reference
10.1007/5584_2016_79
10.1007/5584_2016_79 · External reference
Metabolomics approach reveals effects of antihypertensives and lipid-lowering drugs on the human metabolism
10.1007/s10654-014-9910-7 · 2014 · External reference
Application of plasma lipidomics in studying the response of patients with essential hypertension to antihypertensive drug therapy
10.1039/c1mb05342f · 2011 · External reference
Pharmacometabolomics reveals racial differences in response to atenolol treatment
10.1371/journal.pone.0057639 · 2013 · External reference
Pharmacometabolomic assessments of atenolol and hydrochlorothiazide treatment reveal novel drug response phenotypes
10.1002/psp4.12017 · 2015 · External reference
Effects of four different antihypertensive drugs on plasma metabolomic profiles in patients with essential hypertension
10.1371/journal.pone.0187729 · 2017 · External reference
Metabolomics of interstitial fluid, plasma and urine in patients with arterial hypertension: new insights into the underlying mechanisms
10.3390/diagnostics10110936 · 2020 · External reference
Global metabolic profiling procedures for urine using UPLC-MS
10.1038/nprot.2010.50 · 2010 · External reference
Hypertension pharmacogenomics: in search of personalized treatment approaches
10.1038/nrneph.2015.176 · 2016 · External reference
Pharmacogenomics of hypertension treatment
10.3390/ijms21134709 · 2020 · External reference
Genome-wide association study of young-onset hypertension in the han chinese population of taiwan
2009 · External reference
10.1021/acs.analchem.6b00603
10.1021/acs.analchem.6b00603 · External reference
Controlling the false discovery rate – a practical and powerful approach to multiple testing
10.1111/j.2517-6161.1995.tb02031.x · 1995 · External reference
10.1093/nar/gkn810
10.1093/nar/gkn810 · External reference
10.1093/nar/gkl923
10.1093/nar/gkl923 · External reference
Unresolved reference
External reference
Plasma lipidomic profile signature of hypertension in Mexican American families: specific role of diacylglycerols
10.1161/hypertensionaha.113.01396 · 2013 · External reference
10.1007/bf01931491
10.1007/bf01931491 · External reference
Hypotensive agents and pressor substances - the effect of epinephrine, norepinephrine, angiotensin-ii, and others on the secretory rate of aldosterone in man
10.1001/jama.1960.03030030014003 · 1960 · External reference
The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension
10.1056/nejm199803193381202 · 1998 · External reference
Endothelial dysfunction and hypertensive vasoconstriction
10.1006/phrs.1999.0481 · 1999 · External reference
Lipid second messenger regulation: the role of diacylglycerol kinases and their relevance to hypertension
10.1038/sj.jhh.1001139 · 2001 · External reference
10.1007/s00018-015-1982-3
10.1007/s00018-015-1982-3 · External reference
Lysophosphatidylcholine is generated by spontaneous deacylation of oxidized phospholipids
10.1021/tx100305b · 2011 · External reference
Prehypertension-associated elevation in circulating lysophosphatidlycholines, Lp-PLA(2) activity, and oxidative stress
2014 · External reference
Antibodies to lysophosphatidylcholine are decreased in borderline hypertension
10.1161/01.hyp.37.1.154 · 2001 · External reference
10.1111/j.1527-3466.2007.00004.x
10.1111/j.1527-3466.2007.00004.x · External reference
The hypnotic actions of the fatty acid amide, oleamide
10.1016/s0893-133x(01)00341-4 · 2001 · External reference
10.1038/sj.bjp.0703051
10.1038/sj.bjp.0703051 · External reference
Hypertension: salt restriction, sodium homeostasis, and other ions
10.4103/0019-5359.104787 · 2011 · External reference
Modulation by nitric oxide of hypothalamic GABA and serotonin release: implication for central blood pressure regulation
1997 · External reference
10.1124/pr.111.004697
10.1124/pr.111.004697 · External reference
10.1006/exnr.2001.7792
10.1006/exnr.2001.7792 · External reference
A review on neuropharmacological role of erucic acid: an omega-9 fatty acid from edible oils
10.1080/1028415x.2020.1831262 · 2022 · External reference
Peroxisomal oxidation of erucic acid suppresses mitochondrial fatty acid oxidation by stimulating malonyl-CoA formation in the rat liver
10.1074/jbc.ra120.013583 · 2020 · External reference
Is dietary erucic acid hepatotoxic in pregnancy? An experimental study in rats and hamsters
1995 · External reference
Long-chain monounsaturated fatty acids and incidence of congestive heart failure in 2 prospective cohorts
10.1161/circulationaha.112.001197 · 2013 · External reference
Angiotensin converting enzyme-inhibitory triterpenes from Ganoderma lucidum
10.1248/cpb.34.3025 · 1986 · External reference
Metabolomic signatures for drug response phenotypes: pharmacometabolomics enables precision medicine
10.1002/cpt.134 · 2015 · External reference
Hypertension pharmacological treatment in adults: a world health organization guideline executive summary
10.1161/hypertensionaha.121.18192 · 2022 · External reference
